Go Pro
TSE:IVQ

Invesque Q3 2024 Earnings Report

Invesque logo
C$0.11 0.00 (0.00%)
As of 09:46 AM Eastern

Invesque EPS Results

Actual EPS
-C$0.17
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Invesque Revenue Results

Actual Revenue
$57.82 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Invesque Announcement Details

Quarter
Q3 2024
Time
N/A
Conference Call Date
Wednesday, November 6, 2024
Conference Call Time
6:00PM ET

Earnings Documents

Invesque Earnings Headlines

Invesque Inc. Reports Second Quarter and Year-to-Date Results
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel
See More Invesque Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Invesque? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Invesque and other key companies, straight to your email.

About Invesque

Invesque (TSE:IVQ) is a North American health care real estate company with an investment thesis focused on the premise that an aging demographic will continue to utilize health care services in growing proportion to the overall economy. The Company currently capitalizes on this opportunity by investing in a portfolio of income-generating, private pay seniors housing communities. Invesque's portfolio includes investments in independent living, assisted living, and memory care, which are operated under joint venture arrangements with industry-leading operating partners and in owner-occupied seniors housing properties in which the Company owns the real estate, and the licensed operations.

View Invesque Profile